| Lee, Jeffrey Kuang Zou |
Kaiser Foundation Research Institute
United States |
Multi-Ethnic Multi-Cancer Early Detection and Screening (MED SCREEN) Study |
1UG1CA287011-01 |
|
Elyse LeeVan, M.D., M.P.H. |
| Azizoddin, Desiree R |
University Of Oklahoma Hlth Sciences Ctr
United States |
Leveraging mHealth to deliver integrated pain-CBT, opioid monitoring, and self-management support for advanced cancer patients coping with chronic pain |
5R21CA263838-02 |
|
|
| Brown, Austin L |
Baylor College Of Medicine
United States |
A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia |
5R01CA272981-02 |
|
Rachel Altshuler, Ph.D. |
| Paulovich, Amanda G |
Fred Hutchinson Cancer Center
United States |
Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment |
1U2CCA271873-01A1 |
|
Sidney Fu, M.D. |
| Brenner, Dean E. |
University Of Michigan At Ann Arbor
United States |
Early Phase Clinical Cancer Prevention Consortium |
5UG1CA242632-04 |
RFA-CA-19-031 (UG1 Clinical Trial Required) |
Donald Johnsey |
| Mclouth, Laurie |
University Of Kentucky
United States |
Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment |
1R01CA283929-01 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
| Rajkumar, S Vincent |
Mayo Clinic Rochester
United States |
Onset and biomarkers for progression of monoclonal gammopathies |
5R01CA168762-10 |
|
|
| Lyden, David Charles |
Weill Medical Coll Of Cornell Univ
United States |
Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection |
2R01CA218513-06A1 |
PAR-16-276 (R01) |
Matthew Young, Ph.D. |
| Zheng, Yingye |
Fred Hutchinson Cancer Center
United States |
Statistical Methods for Prospective Evaluation of Biomarkers |
5R01CA236558-14 |
|
Nick Hodges, Ph.D. |
| Singal, Amit |
Ut Southwestern Medical Center
United States |
Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules |
1U01CA283935-01 |
|
Matthew Young, Ph.D. |